A critical breakthrough in cancer investigation is emerging with the use of VHH fragments to restore mutated p53. This vital tumor protector protein is frequently inactivated in many types of cancer, causing https://socialbookmarkgs.com/story21969535/mini-antibodies-reactivate-tumor-suppressor-p53-a-potential-pathway-for-malignant-management